NCT02254746View on ClinicalTrials.gov

A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

November 8, 2023

Conditions
Prostate Adenocarcinoma
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

Trial Locations (1)

1011

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER

NCT02254746 - A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer | Biotech Hunter | Biotech Hunter